The Australian markets settled in green at the end of session on 30th March 2020. The benchmark index S&P/ASX 200 stood at 5181.4 with a rise of 339 points or 7% and, during last five days, S&P/ASX200 has gained 13.98%. Most of the sectors on ASX closed in green such as S&P/ASX 200 Health Care (Sector), which went up by 11.42% to 42,884.1. S&P/ASX 200 Consumer Discretionary (Sector) ended at 1,896.7, reflecting an increase of 8.11%. At the end of same trading session, All Ordinaries ended at 5194 with a rise of 319.8 points.
Let us now look at the performance of some companies on ASX, which performed well. Mayne Pharma Group Limited (ASX: MYX) soared 26.923% and settled at $0.330 per share. Ansell Limited (ASX: ANN) ended at $29.030 with an increase of 25.075% on an intraday basis.
S&P/NZX50 reached at 9,661 with a rise of 0.99%. Cavalier Corporation Limited (NZX: CAV) moved up by 18.75% to NZ$0.190. Kathmandu Holdings Limited (NZX: KMD) inched up by 18.60% and closed at NZ$1.020 per share. On the other hand, Smiths City Group Limited (NZX: SCY) tumbled 42.53% and stood at NZ$0.100.
Recently, we have written an article on engage BDR Limited (ASX: EN1) and readers are advised to view the article by clicking here.
Mayne Pharma Group Limited Rose 26.923% on Australian Stock Exchange
Mayne Pharma Group Limited (ASX: MYX) recently announced that Nick Freeman has stepped down from the designation of Group Chief Financial Officer and Company Secretary. However, MYX has begun its a global search for a new Chief Financial Officer. Mayne has appointed Peter Paltoglou on the role of interim CFO until appointment of new CFO. In another update, the company announced that Investors Mutual Limited has made a change to their substantial holdings in the company. The current voting power stood at 8.70% as compared to the previous voting power of 9.74%. For 1H FY20, the reported revenue of the company stood at $227.2 million with a fall of 17%.
Ansell Limited Ended in Green on 30th March 2020
Ansell Limited (ASX: ANN) has recently stated that it is witnessing robust demand for AlphaTec® hand and body protection products. The company is also experiencing high demand for many of its Microflex® & TouchNTuff® single use examination gloves and for Gammex® & Encore® surgical gloves. Due to uncertainty arising from COVID-19, the company expects rise in delays and possible disruptions in transport and local distribution. The company possesses a strong balance sheet with around $515 million of cash and committed undrawn bank facilities available as at 29th February 2020. For FY20, the company is expecting earnings per share in the range of US112¢ to US122¢.
This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.
There is no investor left unperturbed with the ongoing trade conflicts between US-China and the devastating bushfire in Australia.
Are you wondering if the year 2020 might not have taken the right start? Dividend stocks could be the answer to that question.
As interest rates in Australia are already at record low levels, find out which dividend stocks are viewed as the most attractive investment opportunity in the current scenario in our report.